Benefits of Adherence to 5-alpha Reductase Inhibitor Treatment in Men With Enlarged Prostate: An Assessment of Medicare and Medicaid Patients Using the MarketScan Database
Clinical trial NCT01376258 · COMPLETED
Trial details
- NCT number
- NCT01376258
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2010-10-01
- Primary completion
- 2010-12-01
- Enrollment
- 28903
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.